Fiber-optic probe diagnoses bacterial lung infections quickly

May 3, 2017
A fluorescence detection tool that rapidly diagnoses bacterial lung infections could help prevent unnecessary use of antibiotics.

Doctors currently rely on x-rays and blood tests for diagnosis, but these can be slow and imprecise. Patients are often treated with antibiotics as a precaution, which exposes them to potential side effects.

Recognizing this, University of Edinburgh (Scotland) researchers and colleagues are helping to develop a fluorescence detection tool that rapidly diagnoses bacterial lung infections and, therefore, could help prevent unnecessary use of antibiotics in intensive care units (ICUs). The bedside technology can detect whether harmful bacteria are present within 60 seconds so that patients can be treated with the right medicine quickly.

Related: Infectious disease control with portable CMOS-based diagnostics

The interdisciplinary collaboration, called Proteus, is being led by researchers at the University of Edinburgh, Bath University, and Heriot-Watt University. It is being supported by the UK's Engineering and Physical Sciences Research Council, with additional support from the Wellcome Trust and Medical Research Council.

Proteus uses chemicals that light up when they attach to specific types of bacterial infection. This fluorescence is detected using fiber-optic tubes that are small enough to be threaded deep inside patients' lungs. The probe, which easily reaches parts of the lungs that existing tools cannot, could revolutionize the way critically ill patients (and others with long-term lung conditions) are assessed and treated. It could also aid understanding of bacterial diseases.

Some of the technology developed by the Proteus project to detect infection in the lung. (Image credit: University of Edinburgh)

The research team has been initially focused on helping patients with lung infections and ICU patients with suspected pneumonia who are being ventilated to help them breathe.

Further development of the technology has received £2 million from Wellcome Trust and will receive up to £0.9 million ($1.12 million) from CARB-X, a major international initiative to tackle antibiotic resistance co-funded by the U.S. Government and Wellcome.

For more information, please visit www.eid.ed.ac.uk.

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!